On Friday, Pier 1 Imports Inc (NYSE:PIR)’s shares inclined 0.91% to $12.20.
Pier 1 Imports Inc (PIR) issued a press release announcing that it will distribute its first quarter fiscal 2016 financial results after market close on Wednesday, June 17, 2015, followed by a conference call at 3:30 p.m. Central Time. The call will be hosted by Alex Smith, President and Chief Executive Officer, and Laura Coffey, Executive Vice President and Interim Chief Financial Officer. A copy of this press release is attached hereto as Exhibit 99.1.
Moreover company declared that it will distribute its first quarter fiscal 2016 financial results after market close on Wednesday, June 17, 2015, followed by a conference call at 3:30 p.m. Central Time. The call will be hosted by Alex Smith, President and Chief Executive Officer, and Laura Coffey, Executive Vice President and Interim Chief Financial Officer.
Pier 1 Imports, Inc. engages in the retail sale of decorative home furnishings, furniture, gifts, and related items. The company offers decorative accents and textiles, such as rugs, wall decorations and mirrors, pillows, bedding, lamps, vases, dried and artificial flowers, baskets, ceramics, dinnerware, candles, fragrance, gift, and seasonal items.
IMAX Corporation (USA) (NYSE:IMAX)’s shares gained 2.24% to $42.47.
IMAX Corporation (USA) (IMAX) and Novo Cinemas, the Middle East’s largest chain of theatres, recently declared an expansion of its partnership via a contract for two IMAX® theatres in Dubai featuring IMAX’s next-generation laser projection and sound technology. The theatres will be added to two new complexes: IMG Worlds of Adventure, the world’s largest temperature-controlled indoor theme park spanning 1.5 million square feet, and at the Wafi Mall Shopping Center.
The new agreement brings Novo Cinemas’ IMAX footprint to a total of six, of which two are open - one at Dubai’s Ibn Battuta Mall, the UAE’s only IMAX theatre presently open, and another at The Pearl Mall in Qatar. The exhibitor also has two IMAX theatres contracted to open, with one at the Seef Muharraq Mall in Bahrain and another at the Festival City Mall in Dubai.
IMAX Corporation, together with its auxiliaries, operates as an entertainment technology company specializing in motion picture technologies and presentations worldwide. The company operates in seven segments: IMAX Systems, Theater System Maintenance, Joint Revenue Sharing Arrangements, Film Production and IMAX Digital Re-Mastering (DMR), Film Distribution, Film Post-Production, and Other. The IMAX Systems segment designs, manufactures, sells, or leases IMAX theater projection system equipment. The Theater System Maintenance segment maintains IMAX theater projection system equipment in the IMAX theater network.
At the end of Friday’s trade, POZEN Inc. (NASDAQ:POZN)‘s shares surged 8.19% to $9.25.
POZEN Inc. (POZN) a pharmaceutical company committed to developing medicine that transforms lives, recently declared the acquisition of Tribute Pharmaceuticals Canada Inc. (“Tribute”) (TSX VENTURE:TRX)(TBUFF), a Canadian specialty pharmaceutical company, in a transaction valued at about US$146 million. Upon completion of the acquisition, which is predictable to occur in the fourth quarter of 2015, the combined company will be named Aralez Pharmaceuticals plc (“Aralez” or the “Company”) and domiciled in Ireland. Upon closing, Aralez is predictable to trade on NASDAQ and TSX.
The acquisition will create a premier specialty pharmaceutical company with a broad portfolio of commercial products and a growth plan focused on innovative products and acquisitions and the commercialization of portfolio products in the United States and Canada. The Company will also be well positioned to expand its foreign presence through potential international sales and licensing, manufacturing and product development.
POZEN Inc., a pharmaceutical company, develops products for the treatment of acute and chronic pain, and pain related conditions in the United States and internationally. Its principal PA product candidates comprise PA32540 and PA8140 for secondary prevention of cardiovascular and cerebrovascular disease in patients at risk for gastric ulcers, which have accomplished clinical development in the United States.
New York REIT Inc (NYSE:NYRT), ended its Friday’s trading showed no change, and closed at $9.12.
New York REIT Inc (NYRT) declared that Gregory W. Sullivan has resigned and will be leaving the Company to pursue other interests. He did not resign following any disagreement with the Company and will remain accessible to facilitate a smooth transition. While the Company seeks a replacement for Mr. Sullivan, Nick Radesca, the Company’s former CFO, will serve in this position.
New York REIT, Inc. focuses on acquiring commercial real estate, in addition to acquiring properties or making other real estate investments that relate to office, retail, multi-family residential, industrial, and hotel property types located primarily in New York City. It intends to qualify as a real estate investment trust for the U.S. federal income tax purposes. The company was formerly known as American Realty Capital New York Recovery REIT, Inc. New York REIT, Inc. was founded in October 2009 and is based in New York, New York.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
